|
|
|
||||||||||
Professor, Department of Pharmacy Practice, McWhorter School of Pharmacy, Samford University, Birmingham, AL; Adjunct Associate Research Professor, Department of Neurology, University of Alabama, Birmingham
Reprints: Dr. Welty, Department of Pharmacy Practice, McWhorter School of Pharmacy, Samford University, 800 Lakeshore Dr., Birmingham, AL 35229, fax 205/726-2669, tewelty{at}samford.edu
Generic substitution of antiepileptic drugs is an issue that is gathering a lot of attention in the neurology community but is not receiving much attention within pharmacy. Several proposals have been drafted that restrict a pharmacist's decision-making in generic substitution. These proposals highlight concerns about the pharmacy community related to generic substitution. Careful consideration needs to be given to these issues by pharmacists and pharmacy professional organizations. Unless pharmacy as a profession takes strong positions in support of a pharmacist's ability to make decisions about pharmacotherapy and addresses many of the pharmacy-related problems of generic substitution, policies that negatively impact pharmacy will be established.
Key Words: antiepileptic drugs, epilepsy, generic substitution, pharmacy practice
Published Online, May 15, 2007. www.theannals.com, DOI 10.1345/aph.1K076
This article has been cited by other articles:
![]() |
R. C Hatton Comment: Pharmacy and Generic Substitution of Antiepileptic Drugs: Missing in Action? Ann. Pharmacother., September 1, 2007; 41(9): 1550 - 1551. [Full Text] [PDF] |
||||